Concurrent Investment Advisors, LLC Amneal Pharmaceuticals, Inc. Transaction History
Concurrent Investment Advisors, LLC
- $5.83 Trillion
- Q3 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 34,705 shares of AMRX stock, worth $355,379. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,705Holding current value
$355,379% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
252Shares Held
146MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$180 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$126 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$120 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$116 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$57.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.55B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...